News from jazz pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 22, 2014, 16:05 ET

Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 second quarter financial results on Tuesday, August 5,...

Jul 02, 2014, 08:00 ET

Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has signed a definitive agreement with Sigma-Tau Pharmaceuticals, Inc....

Jun 02, 2014, 14:40 ET

Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a...

May 27, 2014, 16:05 ET

Jazz Pharmaceuticals To Present Data On Compound In Sleep Pipeline During APSS Annual SLEEP Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that new data for the investigational compound JZP-110 (previously ADX-N05) will...

May 19, 2014, 14:00 ET

Jazz Pharmaceuticals Names Russell J. Cox To Position Of Chief Operating Officer

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Russell J. Cox to the newly created position of chief operating officer...

May 13, 2014, 18:15 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...

May 08, 2014, 16:05 ET

Jazz Pharmaceuticals Announces First Quarter 2014 Financial Results

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2014 and reaffirmed and updated...

Apr 24, 2014, 16:05 ET

Jazz Pharmaceuticals to Report 2014 First Quarter Financial Results on May 8, 2014

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 first quarter financial results on Thursday, May 8, 2014,...

Apr 01, 2014, 14:56 ET

Jazz Pharmaceuticals und Gentium kündigen die europäische Markteinführung der ersten zugelassenen lebensrettenden Behandlung bei schwerer Lebervenenverschlusskrankheit an

-- Markteinführung von Defitelio®▼ (Defibrotid) während des 40. Jahrestreffens der European Society for Blood and Marrow...

Apr 01, 2014, 14:41 ET
Apr 01, 2014, 03:24 ET

Jazz Pharmaceuticals y Gentium anuncian el lanzamiento de su tratamiento para la enfermedad venooclusiva hepática

- Jazz Pharmaceuticals y Gentium anuncian el lanzamiento comercial europeo de su primer tratamiento para salvar vidas aprobado para la enfermedad...

Mar 31, 2014, 08:00 ET

Jazz Pharmaceuticals And Gentium Announce European Commercial Launch Of First Approved Life-Saving Treatment For Severe Hepatic Veno-Occlusive Disease

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Gentium S.p.A., a Jazz Pharmaceuticals company, today announced the commencement of the European...

Feb 26, 2014, 18:00 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...

Feb 25, 2014, 16:07 ET

Jazz Pharmaceuticals Announces Management Change

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Kathryn Falberg, executive vice president and chief financial officer (CFO), has...

Feb 25, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2013 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter ended December 31, 2013 and...

Feb 21, 2014, 08:00 ET

Jazz Pharmaceuticals plc Completes Tender Offer For Gentium S.p.A. Shares

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the subsequent offering period of the tender offer made by a subsidiary of...

Feb 11, 2014, 16:07 ET

Jazz Pharmaceuticals to Report 2013 Fourth Quarter and Full Year Financial Results on February 25, 2014

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2013 fourth quarter and full year financial results on...

Feb 11, 2014, 16:05 ET

Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S. commercial availability of Versacloz™ (clozapine, USP) oral suspension, the...

Feb 10, 2014, 08:05 ET

Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland

Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced that it has commenced construction of a manufacturing and development facility to be located on...

Jan 23, 2014, 02:24 ET

Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the initial offering period in the tender offer made by a subsidiary of Jazz...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge